Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE0002EKOXU6
| Stock Name / Fund | iShares Russell 1000 Value UCITS ETF |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | R1VL(USD) LSE |
| ETF Ticker | R1VL.AS(USD) Euronext Amsterdam |
| ETF Ticker | R1VL.L(GBP) LSE |
Holdings detail for XRAY
| Stock Name | Dentsply Sirona Inc |
| Ticker | XRAY(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US24906P1093 |
| LEI | 9NHEHR1SOZCYXDO8HO28 |
Show aggregate XRAY holdings
News associated with XRAY
- Head-To-Head Survey: DENTSPLY SIRONA (NASDAQ:XRAY) and Spotlight Innovation (OTCMKTS:STLT)
- DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and Spotlight Innovation (OTCMKTS:STLT – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares DENTSPLY SIRONA and Spotlight […] - 2025-09-04 05:09:06
- UBS Group Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $24.00
- DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its target price reduced by UBS Group from $25.00 to $24.00 in a research report released on Friday morning,Benzinga reports. UBS Group currently has a buy rating on the medical instruments supplier’s stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a […] - 2025-08-11 02:58:47
- DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to “Hold” Rating by Wall Street Zen
- DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Other equities analysts have also recently issued research reports about the stock. Barrington Research cut their target price on shares of DENTSPLY SIRONA from […] - 2025-08-11 02:58:46
- Stifel Nicolaus Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $17.00
- DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its target price lowered by Stifel Nicolaus from $19.00 to $17.00 in a research note issued to investors on Friday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the medical instruments supplier’s stock. XRAY has been the subject of a number of other research reports. Piper […] - 2025-08-11 02:58:46
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Recommendation of “Hold” by Brokerages
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are currently covering the stock, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target […] - 2025-07-29 02:30:59
- Peek Under The Hood: ONEV Has 10% Upside
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-25 08:58:55
- Envestnet Asset Management Inc. Purchases 40,936 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Envestnet Asset Management Inc. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 494,737 shares of the medical instruments supplier’s stock after buying an additional 40,936 […] - 2025-07-23 04:46:55
- Needham & Company LLC Reaffirms “Hold” Rating for DENTSPLY SIRONA (NASDAQ:XRAY)
- DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued on Monday,Benzinga reports. Several other equities analysts also recently issued reports on XRAY. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating […] - 2025-07-23 03:58:51
- Cwm LLC Buys 52,727 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Cwm LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 124.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 95,087 shares of the medical instruments supplier’s stock after purchasing an additional 52,727 shares during the quarter. Cwm LLC’s holdings in DENTSPLY SIRONA were worth $1,421,000 as of its most […] - 2025-07-21 06:23:36
- Bank of New York Mellon Corp Has $33.80 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Bank of New York Mellon Corp reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 5.9% in the 1st quarter, Holdings Channel reports. The firm owned 2,262,213 shares of the medical instruments supplier’s stock after selling 140,897 shares during the period. Bank of New York Mellon Corp’s holdings in DENTSPLY SIRONA were […] - 2025-07-16 05:16:50
- DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Buy at Wall Street Zen
- DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Sunday. Several other brokerages have also recently issued reports on XRAY. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $27.00 to […] - 2025-07-15 03:07:00
- YieldBoost DENTSPLY SIRONA To 21.8% Using Options
- Shareholders of DENTSPLY SIRONA Inc (Symbol: XRAY) looking to boost their income beyond the stock's 3.9% annualized dividend yield can sell the October covered call at the $17.50 strike and collect the premium based on the 80 cents bid, which annualizes to an additional 17.9% ra - 2025-07-09 12:39:32
- Analyzing DENTSPLY SIRONA (NASDAQ:XRAY) and Green Cures & Botanical Distribution (OTCMKTS:GRCU)
- DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and Green Cures & Botanical Distribution (OTCMKTS:GRCU – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Profitability This table compares DENTSPLY […] - 2025-07-09 05:51:36
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Position Lowered by Amalgamated Bank
- Amalgamated Bank lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 2.4% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 92,303 shares of the medical instruments supplier’s stock after selling 2,285 shares during the period. Amalgamated Bank’s holdings in DENTSPLY SIRONA were worth $1,379,000 at the end of […] - 2025-07-08 05:30:56
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Wealth Enhancement Advisory Services LLC
- Wealth Enhancement Advisory Services LLC increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 39.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53,903 shares of the medical instruments supplier’s stock after acquiring an […] - 2025-07-03 04:26:52
- Envestnet Portfolio Solutions Inc. Sells 4,606 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Envestnet Portfolio Solutions Inc. cut its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 29.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,295 shares of the medical instruments supplier’s stock after selling 4,606 shares during the period. […] - 2025-07-01 04:46:53
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Blue Trust Inc.
- Blue Trust Inc. increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 57.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 12,554 shares of the medical instruments supplier’s stock after purchasing an additional 4,595 shares during […] - 2025-06-25 04:35:09
- Rhumbline Advisers Trims Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Rhumbline Advisers cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 2.3% during the first quarter, HoldingsChannel.com reports. The fund owned 555,008 shares of the medical instruments supplier’s stock after selling 13,241 shares during the quarter. Rhumbline Advisers’ holdings in DENTSPLY SIRONA were worth $8,292,000 at the end of the […] - 2025-06-11 05:46:47
- Merit Financial Group LLC Purchases Shares of 36,649 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Merit Financial Group LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 36,649 shares of the medical instruments supplier’s stock, valued at approximately $548,000. Several other hedge funds have also […] - 2025-06-10 04:45:03
- Public Employees Retirement System of Ohio Has $1.32 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Public Employees Retirement System of Ohio reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 5.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 69,415 shares of the medical instruments supplier’s stock after selling 3,974 shares during […] - 2025-06-03 05:25:01
- Analysts Expect 10% Gains Ahead For The Holdings of DIVB
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-22 07:58:23
- Janus Henderson Group PLC Sells 6,291,054 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Janus Henderson Group PLC lowered its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 98.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,713 shares of the medical instruments supplier’s stock after selling 6,291,054 […] - 2025-05-22 06:49:00
- Nomura Holdings Inc. Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Nomura Holdings Inc. acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 26,376 shares of the medical instruments supplier’s stock, valued at approximately $501,000. Other institutional investors […] - 2025-05-22 06:48:57
- Focus Partners Wealth Acquires Shares of 15,826 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Focus Partners Wealth acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 15,826 shares of the medical instruments supplier’s stock, valued at approximately $300,000. A number of other […] - 2025-05-22 05:20:52
- Captrust Financial Advisors Acquires 6,609 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
- Captrust Financial Advisors boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 39.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,548 shares of the medical instruments supplier’s stock after buying an additional 6,609 […] - 2025-05-20 05:22:52
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Stifel Financial Corp
- Stifel Financial Corp reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 37.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,859 shares of the medical instruments supplier’s stock after selling 11,934 shares during […] - 2025-05-14 04:56:50
- DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Expected to Rise, Barrington Research Analyst Says
- DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) had its target price raised by investment analysts at Barrington Research from $20.00 to $21.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective suggests a potential upside of 26.51% from the […] - 2025-05-14 03:14:50
- DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at StockNews.com
- StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Several other brokerages also recently weighed in on XRAY. Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price […] - 2025-05-12 02:22:42
- Strong Insider Buying Reported in BTAL Holdings
- A look at the weighted underlying holdings of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL) shows an impressive 111.1% of holdings on a weighted basis have experienced insider buying within the past six months.
Match Group Inc (Symbol: MTCH), which makes up 34.16% of the A - 2025-05-08 10:56:10
- DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year Low Following Analyst Downgrade
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday after Piper Sandler lowered their price target on the stock from $20.00 to $16.00. Piper Sandler currently has a neutral rating on the stock. DENTSPLY SIRONA traded as low as $13.38 and last traded at […] - 2025-05-01 04:47:02
iShares Russell 1000 Value UCITS ETF XRAY holdings
| Date | Number of XRAY Shares Held | Base Market Value of XRAY Shares | Local Market Value of XRAY Shares | Change in XRAY Shares Held | Change in XRAY Base Value | Current Price per XRAY Share Held | Previous Price per XRAY Share Held |
|---|
| 2025-11-11 (Tuesday) | 2,340 | USD 25,693 | USD 25,693 | | | | |
| 2025-11-10 (Monday) | 2,340 | USD 25,740 | USD 25,740 | 0 | USD -421 | USD 11 | USD 11.1799 |
| 2025-11-07 (Friday) | 2,340 | USD 26,161 | USD 26,161 | 0 | USD 374 | USD 11.1799 | USD 11.0201 |
| 2025-11-06 (Thursday) | 2,340 | USD 25,787 | USD 25,787 | 0 | USD -3,744 | USD 11.0201 | USD 12.6201 |
| 2025-11-05 (Wednesday) | 2,340 | USD 29,531 | USD 29,531 | 38 | USD 779 | USD 12.6201 | USD 12.49 |
| 2025-11-04 (Tuesday) | 2,302 | USD 28,752 | USD 28,752 | 0 | USD -138 | USD 12.49 | USD 12.55 |
| 2025-11-03 (Monday) | 2,302 | USD 28,890 | USD 28,890 | 0 | USD -138 | USD 12.55 | USD 12.6099 |
| 2025-10-31 (Friday) | 2,302 | USD 29,028 | USD 29,028 | 40 | USD 549 | USD 12.6099 | USD 12.5902 |
| 2025-10-30 (Thursday) | 2,262 | USD 28,479 | USD 28,479 | 0 | USD -610 | USD 12.5902 | USD 12.8599 |
| 2025-10-29 (Wednesday) | 2,262 | USD 29,089 | USD 29,089 | 0 | USD -475 | USD 12.8599 | USD 13.0698 |
| 2025-10-28 (Tuesday) | 2,262 | USD 29,564 | USD 29,564 | 0 | USD -46 | USD 13.0698 | USD 13.0902 |
| 2025-10-27 (Monday) | 2,262 | USD 29,610 | USD 29,610 | 0 | USD -45 | USD 13.0902 | USD 13.1101 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of XRAY by Blackrock for IE0002EKOXU6
Show aggregate share trades of XRAY| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-05 | BUY | 38 | | | 12.620* | | 16.54 |
| 2025-10-31 | BUY | 40 | 12.650 | 12.260 | 12.299 | USD 492 | 16.61 |
| 2025-10-22 | BUY | 39 | 13.030 | 13.180 | 13.165 | USD 513 | 16.75 |
| 2025-10-14 | BUY | 117 | 12.470 | 12.510 | 12.506 | USD 1,463 | 16.89 |
| 2025-09-30 | BUY | 74 | 12.690 | 12.730 | 12.726 | USD 942 | 16.99 |
| 2025-08-04 | BUY | 37 | 14.310 | 14.740 | 14.697 | USD 544 | 17.05 |
| 2025-06-18 | SELL | -38 | 15.400 | 15.590 | 15.571 | USD -592 | 17.30 Profit of 66 on sale |
| 2025-06-02 | SELL | -74 | 15.620 | 15.950 | 15.917 | USD -1,178 | 17.41 Profit of 110 on sale |
| 2025-05-27 | SELL | -37 | 16.340 | 16.370 | 16.367 | USD -606 | 17.45 Profit of 40 on sale |
| 2025-05-21 | BUY | 396 | 15.830 | 16.580 | 16.505 | USD 6,536 | 17.51 |
| 2025-05-12 | BUY | 36 | 16.750 | 17.180 | 17.137 | USD 617 | 17.57 |
| 2025-05-08 | BUY | 144 | 15.910 | 16.090 | 16.072 | USD 2,314 | 17.60 |
| 2025-04-30 | BUY | 35 | 13.900 | 13.940 | 13.936 | USD 488 | 17.83 |
| 2025-04-28 | SELL | -35 | 13.870 | 13.960 | 13.951 | USD -488 | 17.91 Profit of 138 on sale |
| 2025-04-22 | BUY | 72 | 13.020 | 13.090 | 13.083 | USD 942 | 18.04 |
| 2025-04-16 | BUY | 35 | 12.650 | 12.730 | 12.722 | USD 445 | 18.28 |
| 2025-04-09 | BUY | 105 | 13.660 | 13.900 | 13.876 | USD 1,457 | 18.59 |
| 2025-04-04 | SELL | -136 | 13.580 | 13.730 | 13.715 | USD -1,865 | 18.78 Profit of 689 on sale |
| 2025-04-02 | BUY | 68 | 14.870 | 14.920 | 14.915 | USD 1,014 | 18.83 |
| 2025-03-31 | BUY | 34 | 14.940 | 15.100 | 15.084 | USD 513 | 18.93 |
| 2025-03-27 | BUY | 170 | 15.640 | 15.740 | 15.730 | USD 2,674 | 19.02 |
| 2025-02-24 | BUY | 34 | 19.050 | 19.100 | 19.095 | USD 649 | 20.12 |
| 2025-02-12 | BUY | 34 | 18.370 | 18.650 | 18.622 | USD 633 | 20.36 |
| 2025-02-10 | BUY | 68 | 18.460 | 18.850 | 18.811 | USD 1,279 | 20.45 |
| 2025-02-05 | BUY | 33 | 19.290 | 19.770 | 19.722 | USD 651 | 20.54 |
| 2025-01-02 | BUY | 34 | 18.750 | 19.210 | 19.164 | USD 652 | 20.85 |
| 2024-11-18 | BUY | 102 | 18.460 | 18.580 | 18.568 | USD 1,894 | 22.56 |
| 2024-11-08 | BUY | 34 | 17.860 | 18.010 | 17.995 | USD 612 | 23.24 |
| 2024-11-06 | BUY | 64 | 23.980 | 24.860 | 24.772 | USD 1,585 | 23.67 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of XRAY
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 395,702 | 0 | 1,217,727 | 32.5% |
| 2025-09-18 | 434,610 | 0 | 1,179,676 | 36.8% |
| 2025-09-17 | 324,833 | 0 | 1,009,863 | 32.2% |
| 2025-09-16 | 315,146 | 0 | 858,744 | 36.7% |
| 2025-09-15 | 761,108 | 0 | 1,499,955 | 50.7% |
| 2025-09-12 | 579,421 | 0 | 1,125,882 | 51.5% |
| 2025-09-11 | 286,147 | 0 | 533,078 | 53.7% |
| 2025-09-10 | 396,787 | 7 | 834,822 | 47.5% |
| 2025-09-09 | 1,045,737 | 0 | 1,340,666 | 78.0% |
| 2025-09-08 | 375,601 | 44 | 725,537 | 51.8% |
| 2025-09-05 | 275,784 | 0 | 686,022 | 40.2% |
| 2025-09-04 | 867,338 | 6,889 | 1,328,323 | 65.3% |
| 2025-09-03 | 288,266 | 22,730 | 903,071 | 31.9% |
| 2025-09-02 | 333,300 | 0 | 818,657 | 40.7% |
| 2025-08-29 | 200,021 | 2,050 | 574,281 | 34.8% |
| 2025-08-28 | 424,774 | 2,900 | 1,022,589 | 41.5% |
| 2025-08-27 | 335,093 | 0 | 1,625,659 | 20.6% |
| 2025-08-26 | 305,975 | 0 | 708,758 | 43.2% |
| 2025-08-25 | 323,427 | 0 | 726,104 | 44.5% |
| 2025-08-22 | 322,919 | 382 | 710,391 | 45.5% |
| 2025-08-21 | 372,427 | 0 | 699,502 | 53.2% |
| 2025-08-20 | 582,432 | 0 | 1,006,799 | 57.8% |
| 2025-08-19 | 288,793 | 0 | 764,735 | 37.8% |
| 2025-08-18 | 340,343 | 0 | 841,716 | 40.4% |
| 2025-08-15 | 355,584 | 0 | 830,752 | 42.8% |
| 2025-08-14 | 707,081 | 0 | 1,229,035 | 57.5% |
| 2025-08-13 | 695,550 | 0 | 1,699,214 | 40.9% |
| 2025-08-12 | 389,372 | 25 | 1,195,859 | 32.6% |
| 2025-08-11 | 976,087 | 28,860 | 1,881,901 | 51.9% |
| 2025-08-08 | 905,371 | 320 | 2,794,026 | 32.4% |
| 2025-08-07 | 1,653,400 | 427 | 3,105,355 | 53.2% |
| 2025-08-06 | 740,347 | 0 | 2,419,782 | 30.6% |
| 2025-08-05 | 557,371 | 78 | 1,551,525 | 35.9% |
| 2025-08-04 | 227,273 | 0 | 1,105,332 | 20.6% |
| 2025-08-01 | 328,485 | 0 | 2,162,274 | 15.2% |
| 2025-07-31 | 430,131 | 8 | 1,954,997 | 22.0% |
| 2025-07-30 | 386,468 | 20 | 987,225 | 39.1% |
| 2025-07-29 | 337,028 | 19 | 702,474 | 48.0% |
| 2025-07-28 | 530,918 | 500 | 975,948 | 54.4% |
| 2025-07-25 | 336,787 | 66 | 1,165,355 | 28.9% |
| 2025-07-24 | 325,052 | 0 | 743,496 | 43.7% |
| 2025-07-23 | 563,473 | 0 | 3,506,922 | 16.1% |
| 2025-07-22 | 835,778 | 110 | 2,272,479 | 36.8% |
| 2025-07-21 | 795,424 | 1 | 2,992,843 | 26.6% |
| 2025-07-18 | 227,609 | 0 | 535,535 | 42.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.